Virax Biolabs Group Limit...
(VRAX)
undefined
undefined%
At close: undefined
2.97
-6.31%
Pre-market Jan 07, 2025, 05:37 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| Cash & Equivalents | 3.59M | 9.35M | 21.76K | 17.62K | 22.61K |
| Short-Term Investments | 77.32K | 49.26K | 6.00K | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | 54.50K | n/a |
| Other Long-Term Assets | -49.77K | -178.40K | n/a | n/a | n/a |
| Receivables | 217.84K | n/a | n/a | 928.00 | n/a |
| Inventory | 60.38K | 24.09K | 20.95K | 21.07K | n/a |
| Other Current Assets | 512.78K | 281.48K | 6.00K | n/a | n/a |
| Total Current Assets | 4.38M | 9.63M | 48.71K | 39.62K | 22.61K |
| Property-Plant & Equipment | 1.10M | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | 49.77K | 178.40K | n/a | n/a | n/a |
| Total Long-Term Assets | 1.10M | 178.40K | n/a | 54.50K | n/a |
| Total Assets | 5.48M | 9.81M | 48.71K | 94.12K | 22.61K |
| Account Payables | 45.63K | 159.91K | 846.47K | 217.15K | 212.84K |
| Deferred Revenue | n/a | 38.25K | -0.00 | n/a | -759.37K |
| Short-Term Debt | 47.95K | 146.25K | n/a | n/a | 759.37K |
| Other Current Liabilities | 63.12K | 549.99K | 398.94K | 654.29K | 265.53K |
| Total Current Liabilities | 168.85K | 908.40K | 1.25M | 871.43K | 1.24M |
| Long-Term Debt | 176.34K | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 176.34K | n/a | n/a | n/a | n/a |
| Total Liabilities | 345.19K | 908.40K | 1.25M | 871.43K | 1.24M |
| Total Debt | 224.30K | 146.25K | 3.76K | 179.48K | 759.37K |
| Common Stock | 2.57K | 1.56K | 999.00 | 265.00 | 104.00 |
| Retained Earnings | -18.53M | -11.79M | -6.34M | -4.63M | -3.98M |
| Comprehensive Income | 23.89M | 20.92M | 5.36M | 4.03M | 2.92M |
| Shareholders Equity | 5.37M | 9.13M | -974.58K | -596.18K | -1.06M |
| Total Investments | 77.32K | 49.26K | 6.00K | 54.50K | n/a |